The latest conference call transcript from Edwards Lifesciences Corporation has revealed a remarkable fourth quarter ...
Zacks Investment Research on MSN5h
Analysts Estimate SJW (SJW) to Report a Decline in Earnings: What to Look Out forThe market expects SJW (SJW) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is ...
19h
Edwards maintained its 2025 financial guidance, targeting total company sales of $5.6 billion to $6 billion, with TAVR sales of $4.1 billion to $4.4 billion, TMTT sales of $500 million to $530 million ...
Zacks Investment Research on MSN20h
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key MetricsFor the quarter ended December 2024, Edwards Lifesciences (EW) reported revenue of $1.39 billion, down 9.7% over the same period last year. EPS came in at $0.59, compared to $0.64 in the year-ago ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback